Skip to content

Categories:

Category Archives: Chief executive officer

CEO took roundabout path to Emergent January 7, 2011
Posted in Business, Chief executive officer, El-Hibri, Emergent BioSolutions, Entrepreneur, Food and Drug Administration, Fuad El-Hibri, Trubion Pharmaceuticals, United States, United States Department of Health and Human Services, Vaccine, Yale University, biotechnology.
No comments
Emergent BioSolutions Starts Phase I Clinical Trial for Third Generation Anthrax Vaccine January 4, 2011
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri.
No comments
Emergent BioSolutions Presents Positive Data from Its TRU-016 Program at American Society of Hematology Meeting December 15, 2010
Posted in American Society of Hematology, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, Hematology.
No comments
Fuad El-Hibri Recognized by Vilcek Foundation December 10, 2010
Posted in Chief executive officer, El-Hibri, El-Hibri Fuad, El-Hibri Peace Education Prize, Emergent BioSolutions, Fuad El-Hibri, Peace Education.
No comments
Fuad El-Hibri and the International Biomedical Research Alliance November 13, 2010
Posted in BioThrax, Chief executive officer, El-Hibri, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States.
No comments
Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals November 4, 2010
Posted in Business, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Trubion Pharmaceuticals.
No comments
Emergent BioSolutions to Release Third Quarter 2010 Financial Results and Conduct a Conference Call on November 4, 2010 October 23, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, NYSE, Vaccine.
No comments
Fuad El-Hibri and The National Health Museum September 30, 2010
Posted in Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, National Health Museum.
No comments
Emergent BioSolutions Awarded HHS Contract Valued at up to $186.6 Million to Develop rPA Anthrax Vaccine September 20, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, United States Department of Health and Human Services, Vaccine.
No comments
Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Third Generation Anthrax Vaccine September 10, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Vaccine.
No comments
Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars August 30, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Fuad Elhibri, Scholars Program.
No comments
Colman McCarthy to Receive 2010 EL-HIBRI Peace Education Prize August 23, 2010
Posted in Chief executive officer, El-Hibri Fuad, El-Hibri Peace Education Prize, Emergent BioSolutions, Fuad El-Hibri, United States.
No comments
Emergent BioSolutions to Acquire Trubion Pharmaceuticals August 18, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Shareholders, Trubion Pharmaceuticals.
No comments
Emergent Revises Upward 2010 Financial Forecast August 3, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Maryland, United States, Vaccine.
No comments
Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing Facility July 27, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, Vaccine.
No comments
Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax July 15, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, United States Department of Health and Human Services, Vaccine.
No comments
The El-Hibri Foundation Launches Website July 14, 2010
Posted in Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, Peace Education.
No comments
Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians July 13, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Food and Drug Administration, Fuad El-Hibri, United States Department of Defense, United States Department of Health and Human Services.
No comments
Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments July 7, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, Washington.
No comments
Emergent BioSolutions to Participate in June 2010 Investor Conferences June 7, 2010
Posted in Business, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Healthcare Conference, United States.
No comments
Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland May 18, 2010
Posted in Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Maryland, Tech Council of Maryland, Washington.
No comments
Emergent BioSolutions Hosts Biopreparedness Forum for Members of the NATO Parliamentary Assembly May 11, 2010
Posted in Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, Hudson Institute, North Atlantic Treaty Organization, United States Department of Defense.
No comments
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader March 15, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Ernst & Young Entrepreneur of the Year, Fuad El-Hibri.
No comments
500 Most Influential Muslims: Science and Technology January 6, 2010
Posted in Chief executive officer, El-Hibri Fuad, Emergent BioSolutions, Fuad El-Hibri, Washington.
No comments
Fuad el-Hibri, king of anthrax, wins an award from Ernst & Young December 16, 2009
Posted in Chief executive officer, Emergent BioSolutions, Ernst & Young Entrepreneur of the Year, Federal government of the United States, Washington.
No comments

« Previous Next »